Request for Covid-19 Impact Assessment of this Report
There is an increased use of big data in the healthcare arena, where such records are effectively analysed and conclusions are drawn that makes the entire healthcare system efficient and transparent. Clinical analytics refers to the capture and use of discrete clinical data for quality improvement and clinical benchmarking; clinical decision support; regulatory reporting and compliance. By using this technology, healthcare providers can improve the efficiency of their decision making process by using data-driven decision-making, removes preventable costs and streamlines the whole system.
Presently, clinical data is available in the digital form which enables highly progressive statistical, analytical and mathematical tools to garner high-value information. The end users for healthcare analytics includes healthcare providers, pharmaceuticals, health insurance companies, clinical and medical research bodies/CROs, Biotechnology and others.
Market Dynamic
The major growth drivers for global healthcare clinical analytics market are integration of big data in healthcare, increasing adoption rates of electronic healthcare records, availability of data in digital form, emergence of evidence-based medicine, emphasis on healthcare in emerging economies, return of investments within a short time, technological advancements, increasing usage of data sharing platforms such as social media platforms, blogs, and professional networks and need for cutting cost and increasing efficiency.
Restraints
Some restraining factors for this market are lack of infrastructure for handling and computing loads of data, large initial investments, uncertainty of returns, lack of properly trained IT professionals in healthcare sector and data integrity and safety concerns.
Market Segmentation
The various market segments can be derived on the basis of application, technology, component, deployment and end-user.
On the Basis of Application:
> Regulatory reporting
> Compliance and transparency
> Quality improvement
> Clinical decision support
> Population health management
> Comparative effectiveness
> Public health surveillance
On the Basis of Technology:
> Predictive analytics
> Prescriptive analytics
> Descriptive analytics
On the Basis of Component:
> Software
> Hardware
> Services
On the Basis of Deployment:
> On premise model
> Cloud-based model
On the Basis of End-user:
> Private organization (hospitals, clinics, laboratories)
> Government organization
> Pharmaceuticals
> Biotechnology
> Research institutions
Regional/Geographic Analysis
The market is segmented into North America, Europe, Latin America, Asia Pacific except Japan, Japan, and Middle East and Africa. The North America is expected to dominate the market. North America will be followed by Europe. The large share of the market in these regions can be attributed to factors such as well-established healthcare infrastructure, growing healthcare mandates to curb rising healthcare costs, growing EHR adoption, and rising government initiatives and increasing adoption of predictive and prescriptive analytics.
Key Players
The key market players in the market are -
> Allscripts Healthcare Solutions Inc.
> Cerner Corp.
> Elsevier B.V.
> IBM Corp.
> Inovalon
> Mckesson Corp
> Optum Inc.
> Oracle Corporation
> SAS Institute Inc.
> Truven Health Analytics Inc.
> Verisk Analytics
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...